首页|自噬与非小细胞肺癌耐药

自噬与非小细胞肺癌耐药

扫码查看
耐药是非小细胞肺癌临床治疗中面临的一个巨大难题,与肿瘤复发和转移密切相关.自噬是一个进化保守的分子生物过程,通过与溶酶体结合降解细胞器和蛋白质以维持细胞稳态.自噬与非小细胞肺癌发展过程及耐药密切相关,并且靶向调节非小细胞肺癌的自噬相关基因可影响药物敏感性,改变非小细胞肺癌的治疗效果.
Autophagy and drug resistance in non-small cell lung cancer
Drug resistance is a huge challenge in the clinical treatment of non-small cell lung cancer,which is close-ly related to tumor recurrence and metastasis.Autophagy is an evolutionarily conserved metabolic process in eukaryotes.It maintains cell homeostasis by regulating organelles and protein degradation.Autophagy is tightly correlated with the de-velopment process and drug resistance of non-small cell lung cancer,and targeting autophagy-related genes of non-small cell lung cancer can affect drug sensitivity and alter the therapeutic effect of non-small cell lung culture.

AutophagyNon-small cell lung cancerDrug resistance

吕莹、相龙全

展开 >

济宁医学院临床医学院,济宁 272013

济宁市第一人民医院病理科,济宁 272011

自噬 非小细胞肺癌 耐药

国家自然科学基金

81803097

2024

济宁医学院学报
济宁医学院

济宁医学院学报

影响因子:0.513
ISSN:1000-9760
年,卷(期):2024.47(1)
  • 5